SHINE to Move HQ to Janesville, Wisconsin

2017-10-16T08:50:08+00:00

September 23, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year.

SHINE to Move HQ to Janesville, Wisconsin 2017-10-16T08:50:08+00:00

SHINE to Present at Mo-99 Topical Meeting

2017-08-01T08:36:30+00:00

September 6, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE to Present at Mo-99 Topical Meeting 2017-08-01T08:36:30+00:00

George Hansrote Joins SHINE

2017-08-01T08:37:45+00:00

July 13, 2016 - SHINE Medical Technologies announced today that George Hansrote will join the company as Vice President of Project Delivery, to manage the construction of the SHINE radioisotope production facility.

George Hansrote Joins SHINE 2017-08-01T08:37:45+00:00

HTA and SHINE Sign Mo-99 Supply Agreement

2017-09-20T14:06:00+00:00

June 21, 2016 - HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99).

HTA and SHINE Sign Mo-99 Supply Agreement 2017-09-20T14:06:00+00:00

NRC Issues SHINE Construction Permit

2017-10-16T08:36:46+00:00

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

NRC Issues SHINE Construction Permit 2017-10-16T08:36:46+00:00

SHINE CEO Awarded Top Honors by UW

2017-08-01T08:54:46+00:00

January 11, 2016 - The University of Wisconsin-Madison College of Engineering has awarded Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies, Inc. (SHINE) the Early-Career Achievement Award.

SHINE CEO Awarded Top Honors by UW 2017-08-01T08:54:46+00:00

SHINE Holds 2nd 2015 Community Meeting

2017-08-01T08:40:34+00:00

December 7, 2015 - SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.

SHINE Holds 2nd 2015 Community Meeting 2017-08-01T08:40:34+00:00

It Takes Two: GE Healthcare and SHINE Team Up

2017-12-18T18:11:06+00:00

November 9, 2015 - Today, SHINE and GE Healthcare announced they have successfully obtained pharmaceutical-grade Tc‑99m from GE Healthcare’s DRYTEC™ Tc-99m (Kit for the Preparation of Sodium Pertechnetate Technetium Tc99m Injection), using Mo-99 produced by SHINE’s innovative process.

It Takes Two: GE Healthcare and SHINE Team Up 2017-12-18T18:11:06+00:00

SHINE Achieves Major Milestone on Path to Construction Permit Approval

2017-07-31T18:53:28+00:00

October 26, 2015 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility.

SHINE Achieves Major Milestone on Path to Construction Permit Approval 2017-07-31T18:53:28+00:00